|
How many volunteers were present at the Congress? : |
Near 22300 |
|
Delegates from which countries presented in the congress? : |
throughout the world like USA, Canada, Japan,from Europe: Norway, England,Netherlands, Sweden, Italy,... |
|
Were the delegates of any other organizations present in the congress? : |
No |
|
If yes, please write the names of the organizations in the box : |
|
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
My poster presentation was about colon cancer screening among a high-risk population in Iran. I displayed my poster on 9th Oct and was available for Q&A representing my work. Our study confirms that relatives of colon cancer patients in Iran are high risk for colon cancer. The relatively high number of asymptomatic cancer cases among family members of colon cancer patients calls for a nationwide screening program among these high-risk individuals in Iran. In general the response to my presentation was good and there was some questions that were dressed and responded while presenting my poster. |
|
If you met staff members, please list their full names & positions. : |
|
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
No fallow up actions needed. It was a very well organized congress. All sessions was very useful but given the relevancy to my work I enjoyed more from cancer prevention and screening sessions and palliative care sessions. Also I displayed my poster on 9th Oct and was available for Q&A presenting my work. I plan to make efforts for the translation of the knowledge from the congress into our health care system. |
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
good |
|
Please give a briefing of your own observations and outcomes of the congress: : |
It was a very well organized congress. All sessions was very useful but given the relevancy to my work I enjoyed more from cancer prevention and screening sessions and palliative care sessions. Also I displayed my poster on 9th Oct and was available for Q&A to present my work.
Given that the relative risk of developing cancer among First degree relatives (FDRs) of patients with colorectal cancer is two- to three folds greater than the general population, screening colonoscopy in our country should be implemented for at least these high-risk populations. Morovere, we previously showed
that family history of colon cancer was common among colon cancer patients in Iran, particularly if the proband was young.
I plan to make efforts for the translation of the knowledge from the congress into our health care system by implementing screening colonoscopy. |